GlobeImmune, Inc.
GBIM
$0.0002
$0.000.00%
OTC PK
| 03/31/2016 | 12/31/2015 | 09/30/2015 | 06/30/2015 | 03/31/2015 | |
|---|---|---|---|---|---|
| Net Income | 44.75% | 54.35% | 114.05% | 77.16% | 36.17% |
| Total Depreciation and Amortization | -75.82% | -74.64% | -73.24% | -4.48% | 13.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.55% | 65.35% | -102.57% | -98.12% | 125.18% |
| Change in Net Operating Assets | 61.33% | -66.89% | -189.94% | 41.91% | 51.19% |
| Cash from Operations | 50.37% | 31.07% | 38.21% | 24.08% | 25.89% |
| Capital Expenditure | -- | 100.00% | 97.75% | 93.90% | -298.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 127.51% | 434.83% | 93.90% | -119.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.85% | 32.97% | -108.60% | 27.70% | -174.60% |